Alice L Yu Selected Research

Alice L Yu Research Topics

Disease

56	Neoplasms (Cancer) 12/2023 - 11/2002
33	Neuroblastoma 08/2023 - 05/2002
24	Breast Neoplasms (Breast Cancer) 01/2023 - 08/2008
6	Pain (Aches) 01/2020 - 01/2009
6	Macular Degeneration (Age-Related Maculopathy) 12/2014 - 04/2008
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2010 - 03/2002
5	Infections 01/2017 - 06/2006
5	Glaucoma 01/2015 - 11/2008
4	Fever (Fevers) 12/2022 - 01/2009
4	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2011
4	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 02/2006 - 03/2002
3	Cholangiocarcinoma 12/2023 - 01/2022
3	Hypersensitivity (Allergy) 12/2022 - 09/2010
3	Hypotension (Low Blood Pressure) 12/2022 - 01/2009
3	Hyperalgesia 01/2020 - 04/2010
3	Capillary Leak Syndrome 01/2018 - 01/2009
3	Hypoxia (Hypoxemia) 01/2017 - 04/2007
3	Kidney Neoplasms (Kidney Cancer) 01/2017 - 08/2013
3	Leukemia 10/2012 - 11/2002
2	Hepatocellular Carcinoma (Hepatoma) 06/2023 - 01/2017
2	Disease Progression 01/2022 - 05/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 08/2013
2	Residual Neoplasm 12/2014 - 09/2013
2	Optic Nerve Diseases (Optic Neuropathy) 03/2013 - 01/2012
2	Lung Neoplasms (Lung Cancer) 01/2013 - 06/2007
1	Genomic Instability 12/2023
1	Carcinogenesis 01/2023
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2023
1	Mouth Neoplasms (Oral Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

15	dinutuximabIBA 01/2023 - 01/2009
14	Globo-HIBA 06/2023 - 08/2008
14	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2004
9	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023 - 01/2009
9	Monoclonal AntibodiesIBA 01/2017 - 04/2010
8	Messenger RNA (mRNA)IBA 01/2022 - 04/2007
8	Polysaccharides (Glycans)IBA 01/2021 - 08/2008
8	GlycolipidsIBA 11/2020 - 06/2007
7	Interleukin-2 (IL2)IBA 12/2022 - 01/2009
7	Isotretinoin (Accutane)FDA LinkGeneric 01/2018 - 09/2010
6	Aldehyde DehydrogenaseIBA 01/2023 - 10/2011
6	AntioxidantsIBA 12/2014 - 04/2008
5	Biomarkers (Surrogate Marker)IBA 12/2023 - 10/2010
4	RNA (Ribonucleic Acid)IBA 12/2023 - 10/2004
4	GlycosphingolipidsIBA 06/2023 - 10/2016
4	AntigensIBA 01/2023 - 06/2006
4	CeramidesIBA 01/2023 - 12/2014
4	LigandsIBA 01/2023 - 01/2017
4	CarbohydratesIBA 01/2023 - 08/2008
4	VaccinesIBA 01/2022 - 08/2008
4	CytokinesIBA 01/2021 - 06/2007
4	Galactosylceramides (Galactocerebrosides)IBA 02/2014 - 04/2011
4	AntibodiesIBA 01/2014 - 08/2008
3	3-Iodobenzylguanidine (Iobenguane)IBA 08/2023 - 05/2012
3	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 01/2017
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 01/2017
3	LipidsIBA 01/2021 - 01/2017
3	EpitopesIBA 01/2020 - 08/2008
3	englerin AIBA 01/2017 - 08/2013
3	VimentinIBA 08/2014 - 10/2011
2	Cadherins (E-Cadherin)IBA 12/2023 - 10/2011
2	EnzymesIBA 01/2023 - 01/2017
2	temsirolimus FDA Link 01/2023 - 01/2017
2	globo H-KLH vaccineIBA 01/2022 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2022 - 02/2013
2	Small Interfering RNA (siRNA)IBA 01/2021 - 05/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 11/2002
2	Glycoproteins (Glycoprotein)IBA 01/2021 - 12/2012
2	Complement System Proteins (Complement)IBA 01/2021 - 04/2010
2	Hormones (Hormone)IBA 07/2020 - 01/2020
2	Cell-Free Nucleic AcidsIBA 01/2019 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 10/2004
2	Protein Isoforms (Isoforms)IBA 01/2017 - 04/2007
2	Plant ExtractsIBA 01/2017 - 08/2013
2	Peptides (Polypeptides)IBA 01/2016 - 04/2012
2	Phosphotransferases (Kinase)IBA 08/2013 - 10/2004
2	Stage-Specific Embryonic AntigensIBA 02/2013 - 08/2008
2	MicroRNAs (MicroRNA)IBA 01/2013 - 10/2010
2	GangliosidesIBA 12/2012 - 04/2010
2	cluvenoneIBA 10/2012 - 11/2010
2	Transforming Growth Factor beta (TGF-beta)IBA 02/2009 - 04/2007
2	alpha-galactosylceramideIBA 08/2008 - 06/2007
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 12/2023
1	Recombinant DNA (Recombinant DNA Research)IBA 12/2023
1	TransposasesIBA 12/2023
1	ChromatinIBA 12/2023
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2023
1	Gemcitabine FDA Link 01/2023
1	Mucin-4IBA 01/2023
1	matrigelIBA 12/2022
1	NucleophosminIBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022

Therapy/Procedure

36	Therapeutics 08/2023 - 05/2002
20	Immunotherapy 01/2023 - 08/2008
5	Drug Therapy (Chemotherapy) 08/2023 - 03/2002
3	Precision Medicine 01/2022 - 01/2022
3	Stem Cell Transplantation 09/2013 - 09/2010
2	Induction Chemotherapy 11/2019 - 09/2013
2	Radiotherapy 07/2019 - 09/2013
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2013 - 01/2009
1	Transplantation 08/2023